Teva might be known for its sandals, but its new Trailwinder Hiking Shoe was great for dry land trail excursions. The post ...

The biggest mistake I made in Nashville was miscalculating how epic this city really is. While you can see a lot in four days ...

From sandals to sneakers, these will let you enjoy a full day of sightseeing without having to find somewhere to sit every ...

I first bought the Teva Sport Sandals for a trip to Morocco and they have since became my go-to sandals. Not only do they provide me with pain-free wear but the sleek, minimalist design allows me ...

Teva Pharmaceuticals’TEVA0.63%increase; green up pointing triangle shares soared and Sanofi’sSAN-0.33%decrease; red down pointing triangle stock moved higher following positive results from ...

Get your steps in with these comfy and supportive expert-approved walking shoes. (Zappos, Amazon) Whether you’re strolling around the city or hitting the trails this winter, having the right ...

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those taking placebo treatment. Teva announced it was partnering with Sanofi to ...

On Tuesday, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC ...

ADRs of Teva Pharmaceutical (NYSE:TEVA) and Sanofi (NASDAQ:SNY) traded higher in the premarket on Tuesday after the companies said that their experimental antibody therapy, duvakitug, reached the ...

Merck is working on the monoclonal antibody MK-7240—formerly known as PRA023—which it acquired in its $10.8 billion buyout of Prometheus Biosciences last year. In phase 2 results disclosed in ...

Teva Pharmaceuticals' shares soared and Sanofi's stock moved higher following positive results from the latest trial of their jointly developed treatment for inflammatory bowel disease. The ...

17 story has been corrected to say the results were for ulcerative colitis, not for both the diseases, in paragraph 5) Teva and Sanofi said last year they would collaborate on developing a ...